|
Currently, William H. Carson is Chairman of Decibel Therapeutics, Inc. and Chairman of Otsuka Pharmaceutical Development & Commercialization, Inc.
He is also Chairman of Sozosei Foundation and on the board of 5 other companies.
He received a doctorate from Case Western Reserve University and an undergraduate degree from Harvard College.
|
Postes et responsabilités de William H. Carson | |
|
Nom | Titre |
Depuis |
Annexon, Inc. (Produits pharmaceutiques) |
Independent Director |
- | Decibel Therapeutics, Inc. (Recherche biotechnologique et médicale) |
Chairman |
2021 | Otsuka Pharmaceutical Development & Commercialization, Inc. |
Chairman |
2020 | Sozosei Foundation |
Chairman |
2020 | Pharmaceutical Research & Manufacturers of America |
Director |
- | Internet2 |
Trustee |
2018 | Excision BioTherapeutics, Inc. |
Director |
2019 | Sphinx Organization, Inc. |
Chairman-Emeritus |
- |
|
Participations de William H. Carson | |
|
Nom | Actions | % | Valorisation |
Annexon, Inc. (ANNX) (Produits pharmaceutiques) | 0 | 0,0000% | 0 USD |
|
William H. Carson: Réseau personnel | |
|
Nom | Sociétés liées |
Robert McQuade | Otsuka Pharmaceutical Development & Commercialization, Inc. |
Michael Overdorf | Annexon, Inc. |
Bettina M. Cockroft | Annexon, Inc. |
Muneer A. Satter | Annexon, Inc. |
Thomas G. Wiggans | Annexon, Inc. |
Matthew Foy | Decibel Therapeutics, Inc. |
Jung E. Choi | Annexon, Inc. |
Douglas Love | Annexon, Inc. |
John J. Lee | Decibel Therapeutics, Inc. |
Cynthia Wong Hu | Decibel Therapeutics, Inc. |
|
© 2022 People and Ownership :
|
William H. Carson : Connexions | |
|
|
|